BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38001745)

  • 21. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results.
    Kaouk JH; Hafron J; Goel R; Haber GP; Jones JS
    BJU Int; 2008 Jul; 102(1):93-6. PubMed ID: 18410443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.
    Devos B; Al Hajj Obeid W; Andrianne C; Diamand R; Peltier A; Everaerts W; Van Poppel H; Van Velthoven R; Joniau S
    World J Urol; 2019 Aug; 37(8):1507-1515. PubMed ID: 30666400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
    Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
    Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.
    Herrera-Caceres JO; Nason GJ; Salgado-Sanmamed N; Goldberg H; Woon DTS; Chandrasekar T; Ajib K; Tan GH; Alhunaidi O; van der Kwast T; Finelli A; Zlotta AR; Hamilton RJ; Berlin A; Perlis N; Fleshner NE
    BJU Int; 2020 Apr; 125(4):525-530. PubMed ID: 31863617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
    Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
    Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
    Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of salvage radical prostatectomy following more than one failed local therapy.
    Sivaraman A; Scardino P; Eastham J
    Investig Clin Urol; 2018 May; 59(3):152-157. PubMed ID: 29744471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
    Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
    Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Review of Focal and Salvage Cryotherapy for Prostate Cancer.
    Chin YF; Lynn N
    Cureus; 2022 Jun; 14(6):e26400. PubMed ID: 35911314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?
    Marra G; Calleris G; Alessio P; Oderda M; Palou J; Joniau S; Piechaud T; Smelzo S; Morlacco A; Sharma V; Tilki D; Van der Poel H; Veerman H; Karnes RJ; Gontero P
    Eur Urol Focus; 2021 Jul; 7(4):807-811. PubMed ID: 32414618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review.
    Nicoletti R; Alberti A; Castellani D; Yee CH; Zhang K; Poon DMC; Chiu PK; Campi R; Resta GR; Dibilio E; Pirola GM; Chiacchio G; Fuligni D; Brocca C; Giulioni C; De Stefano V; Serni S; Gauhar V; Ng CF; Gacci M; Teoh JYC
    Prostate Cancer Prostatic Dis; 2023 Jul; ():. PubMed ID: 37507479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
    Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH
    Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
    Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
    Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
    [No Abstract]   [Full Text] [Related]  

  • 34. Oncological and functional results of robotic salvage radical prostatectomy after permanent brachytherapy implants.
    Orré M; Piéchaud T; Sargos P; Richaud P; Roubaud G; Thomas L
    Cancer Radiother; 2017 Apr; 21(2):119-123. PubMed ID: 28396223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
    Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
    Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
    Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments.
    Marra G; Calleris G; Massari E; Vissio E; Molinaro L; Cassoni P; D'Agate D; Oderda M; Valerio M; Raskin Y; Joniau S; Papotti M; Gontero P
    Eur Urol Open Sci; 2023 Jan; 47():110-118. PubMed ID: 36601045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
    Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
    Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.